Subscribe for email alerts

Don’t miss a single Science & Enterprise post. Sign up for our daily email alerts.

Please share Science & Enterprise

Delivery Tech Licensed for CBD Epilepsy Nasal Spray

Blooming cannibis plant

A company is developing a nasal spray for epilepsy symptoms with a cannabis extract delivered in nanoscale polymer particles to the brain. . . . → Read More: Delivery Tech Licensed for CBD Epilepsy Nasal Spray

FDA Okays One-Time HIV Treatment Clinical Trial

HIV released from cell

A company developing a one-time treatment for HIV infections using the gene-editing technique Crispr says it received FDA clearance to begin a clinical trial. . . . → Read More: FDA Okays One-Time HIV Treatment Clinical Trial

Pharma, Synthetic Bio Companies to Find Antibody Therapies

DNA chip graphic

A pharmaceutical company and developer of synthetic genomic materials are collaborating on discovery of therapeutic antibodies to treat a range of diseases. . . . → Read More: Pharma, Synthetic Bio Companies to Find Antibody Therapies

Biotech Start-Up Gains $90M for Neurodegenerative Diseases

Mature neuron

A one year-old biotechnology company developing treatments for diseases of microglia cells in the brain, is raising $90 million in new venture funds. . . . → Read More: Biotech Start-Up Gains $90M for Neurodegenerative Diseases

New Company Forms to Ease Scientific Data Operations

Data pointing finger

A new company spun off from Harvard University aims to simplify data analysis, management, and collaboration for life science researchers. . . . → Read More: New Company Forms to Ease Scientific Data Operations

Pharma Gains Synthetic DNA for Rare Diseases in $1B+ Deal

Brain activity graphic

A French biopharmaceutical company is gaining access to a technology using synthetic nucleic acids to treat rare genetic neurological diseases. . . . → Read More: Pharma Gains Synthetic DNA for Rare Diseases in $1B+ Deal

Pharma, Biotech Partner on Off-the-Shelf Cell Therapies

Mitochondria illustration

A biotechnology enterprise is teaming with a pharmaceutical company to develop off-the-shelf therapies for malfunctioning mitochondria, energy centers of cells. . . . → Read More: Pharma, Biotech Partner on Off-the-Shelf Cell Therapies

Fine-Tuning Process Devised for Gene Therapies

Gene therapy graphic

Researchers designed a technique to adjust the volume of proteins from gene therapy released into patients, providing more control for complex diseases. . . . → Read More: Fine-Tuning Process Devised for Gene Therapies

3-D Printed Scaffold Helps Regrow Soft Tissue

Printed tissue scaffolds

Researchers developed a biodegradable polymer for printed implant scaffolds that in lab rodents maintains its shape to encourage cell and tissue growth. . . . → Read More: 3-D Printed Scaffold Helps Regrow Soft Tissue

GSK, Biotech Partner on Neuro Antibodies in $2.2B Deal

Brain activity graphic

GlaxoSmithKline and biotechnology company Alector Inc. agreed to co-develop two synthetic antibodies for treating neurodegenerative disorders. . . . → Read More: GSK, Biotech Partner on Neuro Antibodies in $2.2B Deal